Benzinga | Dec 29, 2020 06:11AM EST

HC Wainwright & Co. Initiates Coverage On Tenax Therapeutics with Buy Rating, Announces Price Target of $5

HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Buy rating and announces Price Target of $5.